Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hartmann

Showing results (221-230 of 288) with videos related to

Pageof 29
Sort By:
Biochemical and Biophysical Research Communications|November 1, 1996
Detection of a secreted MUC1/SEC protein by MUC1 isoform specific monoclonal antibodiesN Smorodinsky, M Weiss, M L Hartmann, et al.
Transplantation Proceedings|April 26, 2005
Pilot study of rapid steroid elimination with alemtuzumab induction therapy in kidney and pancreas transplantationA K Sundberg, J A Roskopf, E L Hartmann, et al.
Transplantation Proceedings|November 22, 2005
Successful simultaneous kidney-pancreas transplantation from extreme donorsR J Stratta, A K Sundberg, A C Farney, et al.
Transplantation Proceedings|November 22, 2005
Experience with alternate-day thymoglobulin induction in pancreas transplantation with portal-enteric drainageR J Stratta, A K Sundberg, A C Farney, et al.
Oncogene|September 1, 1999
c-Myc does not prevent glucocorticoid-induced apoptosis of human leukemic lymphoblastsM Löffler, M J Ausserlechner, M Tonko, et al.
Oncogene|August 13, 1999
A novel region of deletion on chromosome 6q23.3 spanning less than 500 Kb in high grade invasive epithelial ovarian cancerV Shridhar, J Staub, B Huntley, et al.
Cancer Genetics and Cytogenetics|November 1, 1993
Cytogenetic studies of epithelial ovarian carcinomaR B Jenkins, D Bartelt, P Stalboerger, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 6, 2009
Physical function in older candidates for renal transplantation: an impaired populationErica L Hartmann, Dalane Kitzman, Michael Rocco, et al.
Cancer Research|May 15, 1993
Human epithelial ovarian cancer allelotypeW Cliby, S Ritland, L Hartmann, et al.
FEBS Letters|January 27, 1997
The interleukin 1beta-converting enzyme inhibitor CrmA prevents Apo1/Fas- but not glucocorticoid-induced poly(ADP-ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cellsS Geley, B L Hartmann, K Kapelari, et al.
Pageof 29

Showing results (221-230 of 288) with videos related to

Sort By:
Pageof 29
Biochemical and Biophysical Research Communications|November 1, 1996
Detection of a secreted MUC1/SEC protein by MUC1 isoform specific monoclonal antibodiesN Smorodinsky, M Weiss, M L Hartmann, et al.
Transplantation Proceedings|April 26, 2005
Pilot study of rapid steroid elimination with alemtuzumab induction therapy in kidney and pancreas transplantationA K Sundberg, J A Roskopf, E L Hartmann, et al.
Transplantation Proceedings|November 22, 2005
Successful simultaneous kidney-pancreas transplantation from extreme donorsR J Stratta, A K Sundberg, A C Farney, et al.
Transplantation Proceedings|November 22, 2005
Experience with alternate-day thymoglobulin induction in pancreas transplantation with portal-enteric drainageR J Stratta, A K Sundberg, A C Farney, et al.
Oncogene|September 1, 1999
c-Myc does not prevent glucocorticoid-induced apoptosis of human leukemic lymphoblastsM Löffler, M J Ausserlechner, M Tonko, et al.
Oncogene|August 13, 1999
A novel region of deletion on chromosome 6q23.3 spanning less than 500 Kb in high grade invasive epithelial ovarian cancerV Shridhar, J Staub, B Huntley, et al.
Cancer Genetics and Cytogenetics|November 1, 1993
Cytogenetic studies of epithelial ovarian carcinomaR B Jenkins, D Bartelt, P Stalboerger, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 6, 2009
Physical function in older candidates for renal transplantation: an impaired populationErica L Hartmann, Dalane Kitzman, Michael Rocco, et al.
Cancer Research|May 15, 1993
Human epithelial ovarian cancer allelotypeW Cliby, S Ritland, L Hartmann, et al.
FEBS Letters|January 27, 1997
The interleukin 1beta-converting enzyme inhibitor CrmA prevents Apo1/Fas- but not glucocorticoid-induced poly(ADP-ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cellsS Geley, B L Hartmann, K Kapelari, et al.
Pageof 29